$CELC
Celcuity Inc. Common Stock
XNAS•Health Care•Services-Medical Laboratories
$81.15
▼-4.43%-$3.76
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCelcuity Inc. Common Stock
XNAS•Health Care•Services-Medical Laboratories
Why is CELC down today? It is at $81.15 (-4.43%), and our scanner flagged it 88 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CELC spikes, and full due diligence on CELC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CELC 88 times in the last 30 days. Create a free account to track $CELC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CELC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CELC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCelcuity Submits sNDA to FDA for REVTORPYK (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hahne Vicky Officer | Acquired (grant/award) | +16K 0.03% of company | added 73% | 38K | n/a | Aug 14, 26 |
Sullivan Brian F. Officer | Acquired (grant/award) | +80K 0.2% of company | added 5.8% | 1.45M | n/a | Aug 14, 26 |
Laing Lance G. Officer | Acquired (grant/award) | +20K 0.04% of company | added 1.6% | 1.27M | n/a | Aug 14, 26 |
Baker Bros. Advisors Lp Other | Sold (automatic/other) | -3.10M 6.3% of company | sold 39% | 4.82M | $317.8M at $102.50 | Jul 14, 26 |
Buller Richard E Director | Acquired (grant/award) | +2K | n/a | 2K | n/a | Jun 5, 26 |
Nigon Richard Director | Acquired (grant/award) | +2K | added 1.9% | 81K | n/a | Jun 5, 26 |
Romp Charles R Director | Acquired (grant/award) | +2K | added 100% | 2K | n/a | Jun 5, 26 |
Furcht Leo Director | Acquired (grant/award) | +2K | added 14% | 13K | n/a | Jun 5, 26 |
Dalvey David Director | Acquired (grant/award) | +2K | n/a | 2K | n/a | Jun 5, 26 |
Murphy Polly A. Director | Acquired (grant/award) | +2K | added 31% | 7K | n/a | Jun 5, 26 |
Laing Lance G. Officer | Other | 1K | added <0.1% | 1.25M | $10K at $9.89 | Jun 2, 26 |
Buller Richard E Director | Sold (automatic/other) | -1K | n/a | n/a | n/a | May 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-medical laboratories, closest in size first.
Here is the latest on CELC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CELC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CELC last traded at $81.15, down 4.43% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Celcuity Inc. Common Stock (CELC) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CELC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CELC 88 times in the last 30 days.
CELC (Celcuity Inc. Common Stock) trades on XNAS, with a market cap of about $3.94B in the SERVICES-MEDICAL LABORATORIES sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CELC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CELC discussion
Sign in to ask a question or join the discussion.